Factors associated with quality of life in systemic sclerosis: a cross-sectional study.
Anxiety
/ diagnosis
Anxiety Disorders
/ diagnosis
Cross-Sectional Studies
Depression
/ diagnosis
Depressive Disorder
/ diagnosis
Disability Evaluation
Fatigue
/ diagnosis
Female
Humans
Male
Middle Aged
Pain
/ diagnosis
Poland
Quality of Life
/ psychology
Scleroderma, Systemic
/ psychology
Surveys and Questionnaires
Anxiety
Physical disability
Quality of life
Systemic sclerosis
Journal
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
ISSN: 1573-2649
Titre abrégé: Qual Life Res
Pays: Netherlands
ID NLM: 9210257
Informations de publication
Date de publication:
Dec 2019
Dec 2019
Historique:
accepted:
23
08
2019
pubmed:
5
9
2019
medline:
6
2
2020
entrez:
5
9
2019
Statut:
ppublish
Résumé
Systemic sclerosis (SSc) is a connective tissue disease characterized by progressive fibrosis of the skin and internal organs, leading to their failure and disturbances in the morphology and function of blood vessels. The disease affects people in different ways, and identifying how the difficulties and limitations are related to quality of life may contribute to designing helpful interventions. The aim of this study was to identify factors associated with quality of life in people with SSc. This was a cross-sectional study conducted in 11 rheumatic centres in Poland. Patients diagnosed with SSc were included. Quality of life was measured using the SSc Quality of Life Questionnaire (SScQoL). The following candidate factors were entered in preliminary multivariable analysis: age, place of residence, marital status, occupational status, disease type, disease duration, pain, fatigue, intestinal problems, breathing problems, Raynaud's symptoms, finger ulcerations, disease severity, functional disability, anxiety and depression. Factors that achieved statistical significance at the 10% level were then entered into a final multivariable model. Factors achieving statistical significance at the 5% level in the final model were considered to be associated with quality of life in SSc. In total, 231 participants were included. Mean age (SD) was 55.82 (12.55) years, disease duration 8.39 (8.18) years and 198 (85.7%) were women. Factors associated with quality of life in SSc were functional disability (β = 2.854, p < 0.001) and anxiety (β = 0.404, p < 0.001). This model with two factors (functional disability and anxiety) explained 56.7% of the variance in patients with diffuse SSc and 73.2% in those with localized SSc. Functional disability and anxiety are significantly associated with quality of life in SSc. Interventions aimed at improving either of these factors may contribute towards improving the quality of life of people with SSc.
Identifiants
pubmed: 31482431
doi: 10.1007/s11136-019-02284-9
pii: 10.1007/s11136-019-02284-9
pmc: PMC6863937
doi:
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
3347-3354Subventions
Organisme : Medical University of Bialystok, Poland
ID : UMB (N/ST/ZB/16/002/3310)
Références
Arthritis Rheum. 1980 Feb;23(2):137-45
pubmed: 7362664
Clin Rheumatol. 2012 Aug;31(8):1215-22
pubmed: 22588647
J Rheumatol. 2009 Nov;36(11):2481-6
pubmed: 19797513
BMJ Open. 2013 Aug 07;3(8):
pubmed: 23929922
Rheumatology (Oxford). 2007 May;46(5):872-6
pubmed: 17308314
Reumatismo. 2006 Jul-Sep;58(3):219-25
pubmed: 17013439
Rheumatology (Oxford). 2013 Oct;52(10):1856-64
pubmed: 23843108
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Autoimmun Rev. 2010 Mar;9(5):A311-8
pubmed: 19906362
Qual Life Res. 2004 Mar;13(2):283-98
pubmed: 15085901
Rheumatol Int. 2013 Jul;33(7):1797-804
pubmed: 23306593
Rheumatology (Oxford). 2006 Nov;45(11):1325-7
pubmed: 16908510
J Rheumatol. 2011 Apr;38(4):685-92
pubmed: 21159826
Scand J Rheumatol. 2004;33(2):102-7
pubmed: 15163111
Ann Rheum Dis. 2013 Nov;72(11):1747-55
pubmed: 24092682
Ann Rheum Dis. 2018 Jul;77(7):1032-1038
pubmed: 29463517
Qual Life Res. 2006 Oct;15(8):1383-94
pubmed: 16826439
Joint Bone Spine. 2005 Oct;72(5):408-11
pubmed: 16214073
Pain. 2002 Feb;95(3):267-275
pubmed: 11839426
Rheumatology (Oxford). 2009 Feb;48(2):165-9
pubmed: 19106163
Acta Biomed. 2015 Sep 14;86(2):142-8
pubmed: 26422428
Disabil Rehabil. 2007 Oct 15;29(19):1492-501
pubmed: 17852224
Physiother Can. 2013 Fall;65(4):317-20
pubmed: 24396157
Rheumatol Int. 2018 Aug;38(8):1471-1478
pubmed: 29497844
Ann Rheum Dis. 2017 Aug;76(8):1327-1339
pubmed: 27941129
Ann Rheum Dis. 2019 Jun;78(6):855-857
pubmed: 30610065
Clin Rheumatol. 2005 Feb;24(1):48-54
pubmed: 15300468
Qual Life Res. 2015 Mar;24(3):721-33
pubmed: 25231203
Ann Rheum Dis. 2014 Dec;73(12):2122-9
pubmed: 23921996
Rheumatology (Oxford). 2011 Apr;50(4):762-7
pubmed: 21149249
J Psychosom Res. 2007 Jan;62(1):47-56
pubmed: 17188120